Vuori Kristiina MD
- SEC CIK
- 0001612627
Latest role at each company
- INBX Inhibrx Biosciences, Inc.Directoras of Sep 18, 2026
- CIK 0001829280Directoras of May 15, 2026
- BNGO Bionano Genomics, Inc.Directoras of May 14, 2026
- CIK 0001739614Directoras of May 30, 2024
Trades
Every Form 4 that lists Vuori Kristiina MD as a reporting owner, including filings made jointly with others. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Company | Filed (ET) | Trade date | Insider | Transaction | Shares | Avg price | Value | Shares after | Holding change | Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| INBXInhibrx Biosciences, Inc. | Oct 7, 2024 | Oct 3, 2024 | Vuori Kristiina MDDirector | PPurchaseCommon Stock | +6.67K | $15.00 | +$100.01K | 20.44K | +48.4% | SEC |
| INBXInhibrx Biosciences, Inc. | Sep 12, 2024 | Sep 10 – Sep 11, 2024 | Vuori Kristiina MDDirector | PPurchaseCommon Stock | +6.64K | $15.0681 | +$99.99K | 13.78K | +92.9% | SEC |
| INBXInhibrx Biosciences, Inc. | Sep 3, 2024 | Aug 29, 2024 | Vuori Kristiina MDDirector | PPurchaseCommon Stock | +7.14K | $14.00 | +$99.96K | 7.14K | New position | SEC |